drugset / Trial / NCT01017458

Safety and Tolerability of MK0773 in Healthy Older Men (0773-004)

NCT01017458

Phase 1 Completed 68 enrolled Merck Sharp & Dohme LLC
RandomizedParallel-groupDouble-blindTreatment

Summary

This study will assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of MK0773 in healthy older men.

Timeline

Start
2007-06
Primary completion
2008-08
Completion
2008-08

Drugs

EvaluationDrugModalityDoseRoute
Subject MK0773 Other / unclassified 25 mg Oral
Comparator Testosterone Enanthate Small molecule 200 mg Intramuscular

Indications

No indication recorded.